The global market for brain mapping instruments is expected to expand to USD 3.4 Billion by 2031 at a CAGR of 6.2%. The advancement in embedded artificial intelligence (AI) and machine learning (ML) technologies is set to boost the demand for brain mapping instruments in the upcoming years. The rising incidences of neurological diseases coupled with the rising need for improved and accurate diagnosis is another factor for the surge in brain mapping tool sales in the past few years, majorly...
The global neuroprosthetics market is expected to expand to USD 42.5 Billion by 2031 at a CAGR of 16.2%. The rising number of patients suffering from several neurological, physiological, and cognitive disorders as a large part of the global population is aging is the major factor driving the overall neuroprosthetics market. The advancements in healthcare systems and medical science coupled with the advent of artificial intelligence (AI), have brought new opportunities for the global...
The global smart healthcare market is expected to expand to USD 410.7 Billion by 2031 at a CAGR of 13.4%. The rising geriatric population coupled with the growing desire for patient-centered and individualized treatment is one of the major factors driving the global smart healthcare market. Additionally, with the advent of AI, IoT, and big data analytics, the global smart healthcare market's opportunities have propelled and are anticipated to surge heavily in the upcoming years.
The rising...
The global cannabidiol market is expected to expand to USD 24.2 Billion by 2031 at a CAGR of 16.2%. The global cannabidiol market is dynamic and ever-evolving, with several factors such as opportunities, regulatory bodies, opportunities, and restraints shaping its growth and development. The cannabidiol (CBD) market is driven worldwide by several important factors such as the growing legalization of cannabis-related products in many countries across the globe coupled with the rise in...
The global antihypertensive drugs market size is expected to expand to USD 33.5 Billion by 2031 at a CAGR of 2.7%. The poor lifestyles and disorders linked to it, coupled with the aging population base around the world is the major factor driving the market expansion of antihypertensive drugs. The advancements in personalized medicines leading to fewer adverse effects and better control of hypertension have brought new opportunities for the global antihypertensive drug market to propel in...
The global implantable medical device market size is expected to expand to USD 195 Billion by 2031 at a CAGR of 6.7%. The increasing chronic illness around the globe coupled with the technological advancements in medical science, thereby enhancing the capabilities of medical devices is the major factor driving the global implantable medical devices market. There has also been a rise in startups providing neuromodulation in recent years. The heavy investment by the key players in the market...
The global radiopharmaceuticals market is anticipated to reach USD 11.3 Billion by 2030 at a 9.7% CAGR during the forecast period. The market is a quickly developing area of nuclear medicine, propelled by the rising incidence of cardiovascular and cancerous conditions, the aging of the population, and improvements in medical imaging techniques like PET and SPECT. Nuclear medicine procedures have increased dramatically in recent years, with radiopharmaceuticals playing a critical role in...
